Trials / Completed
CompletedNCT02586259
Effectiveness of Cortiment® in Patients With Ulcerative Colitis
A Prospective Multi-centre Observational Cohort Study Assessing the Effectiveness of Cortiment® for the Treatment of Mild-to-moderate Active Ulcerative Colitis in Routine Clinical Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 378 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate Cortiment® with regard to its use by clinicians in routine clinical practice and its effectiveness and tolerability in a real-life setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | budesonide MMX® |
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2018-04-05
- Completion
- 2018-04-05
- First posted
- 2015-10-26
- Last updated
- 2019-11-20
Locations
8 sites across 8 countries: Canada, Germany, Ireland, Italy, Netherlands, Poland, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT02586259. Inclusion in this directory is not an endorsement.